Dr. Craig B. Thompson, M.D., has been the Chief Executive Officer and President at Memorial Sloan-Kettering Cancer Center since August 2010. Dr. Thompson served as an Associate Vice President for Cancer Services of the University of Pennsylvania Health System, Inc. He has experience in the design, implementation and evaluation of clinical trials. He serves as the Chairman and Member of Advisory Board of Howard Hughes Medical Institute. He is a Co-Founder of Agios Pharmaceuticals, Inc. and serves as its Chairman of Scientific Advisory Board. He serves on the Advisory Boards of St. Jude Children's Research Hospital and M.D. Anderson Cancer Center. He has been an Independent Director at Merck & Co., Inc. since January 1, 2008. He serves as a Member of Scientific Advisory Board at Pancreatic Cancer Action Network, Inc. Dr. Thompson serves as a Member of Scientific Advisory Board of Idun Pharmaceuticals, Inc. Dr. Thompson served as a Director of Abramson Family Cancer Research Institute since 2006. He served as Member of scientific Advisory Board at Xcyte Therapies Inc. He served as a Director at Schering-Plough Corp. since January 2, 2008. Dr. Thompson served as a Director of the Gwen Knapp Center for Immunology as well as the Director of the Fitch Monoclonal Antibody Facility at the University of Chicago from 1993 to 1999. He serves as Professor of Medicine and Chair of the Department of Cancer Biology The University of Pennsylvania School of Medicine since 1999. Dr. Thompson served as a Professor of Medicine, Investigator in the Howard Hughes Medical Institute. He served as a Professor for Department of Medicine at the University of Michigan from 1987 to 1993 and Professor of Medicine at Uniformed Services at University of the Health Sciences from 1982 to 1987. Prior to that, he served as a Senior Fellow of Hematology & Oncology at the Fred Hutchinson Cancer Research Center from 1983 to 1985 and a Physician at the National Naval Medical Center from 1981 to 1983. He also served as Deputy Director of the Leonard and Madlyn Abramson Family Cancer Research Institute of the University of Pennsylvania. His duties include acting as the Director's Chief Advisor on major decisions related to the Cancer Research Institute's activities, plans and actions. His lab has made important contributions to the understanding of basic immunology, Oncogene function, cell cycle control and apoptosis. He serves as a Director of AMDeC, LLC. He has been an Independent Director at Charles River Laboratories International, Inc. since December 2, 2013. He serves as a Director, American Association for Cancer Research. He is Fellow, American Academy of Arts and Sciences. He is a Member of the National Academy of Sciences of American Academy of Sciences and its Institute of Medicine. He is a Board-Certified Medical Oncologists. He serves as a Director of AMDeC Foundation, Inc. Dr. Thompson is an authority in the study of how genes regulate apoptosis and metabolism and investigates their application in treating cancer. Dr. Thompson holds a Bachelor's Degree in Medical Science from Dartmouth College and an M.D. from the University of Pennsylvania. Dr. Craig B. Thompson, M.D., has been the Chief Executive Officer and President at Memorial Sloan-Kettering Cancer Center since August 2010. Dr. Thompson served as an Associate Vice President for Cancer Services of the University of Pennsylvania Health System, Inc. He has experience in the design, implementation and evaluation of clinical trials. He serves as the Chairman and Member of Advisory Board of Howard Hughes Medical Institute. He is a Co-Founder of Agios Pharmaceuticals, Inc. and serves as its Chairman of Scientific Advisory Board. He serves on the Advisory Boards of St. Jude Children's Research Hospital and M.D. Anderson Cancer Center. He has been an Independent Director at Merck & Co., Inc. since January 1, 2008. He serves as a Member of Scientific Advisory Board at Pancreatic Cancer Action Network, Inc. Dr. Thompson serves as a Member of Scientific Advisory Board of Idun Pharmaceuticals, Inc. Dr. Thompson served as a Director of Abramson Family Cancer Research Institute since 2006. He served as Member of scientific Advisory Board at Xcyte Therapies Inc. He served as a Director at Schering-Plough Corp. since January 2, 2008. Dr. Thompson served as a Director of the Gwen Knapp Center for Immunology as well as the Director of the Fitch Monoclonal Antibody Facility at the University of Chicago from 1993 to 1999. He serves as Professor of Medicine and Chair of the Department of Cancer Biology The University of Pennsylvania School of Medicine since 1999. Dr. Thompson served as a Professor of Medicine, Investigator in the Howard Hughes Medical Institute. He served as a Professor for Department of Medicine at the University of Michigan from 1987 to 1993 and Professor of Medicine at Uniformed Services at University of the Health Sciences from 1982 to 1987. Prior to that, he served as a Senior Fellow of Hematology & Oncology at the Fred Hutchinson Cancer Research Center from 1983 to 1985 and a Physician at the National Naval Medical Center from 1981 to 1983. He also served as Deputy Director of the Leonard and Madlyn Abramson Family Cancer Research Institute of the University of Pennsylvania. His duties include acting as the Director's Chief Advisor on major decisions related to the Cancer Research Institute's activities, plans and actions. His lab has made important contributions to the understanding of basic immunology, Oncogene function, cell cycle control and apoptosis. He serves as a Director of AMDeC, LLC. He has been an Independent Director at Charles River Laboratories International, Inc. since December 2, 2013. He serves as a Director, American Association for Cancer Research. He is Fellow, American Academy of Arts and Sciences. He is a Member of the National Academy of Sciences of American Academy of Sciences and its Institute of Medicine. He is a Board-Certified Medical Oncologists. He serves as a Director of AMDeC Foundation, Inc. Dr. Thompson is an authority in the study of how genes regulate apoptosis and metabolism and investigates their application in treating cancer. Dr. Thompson holds a Bachelor's Degree in Medical Science from Dartmouth College and an M.D. from the University of Pennsylvania.

Pathology